Use of antibody/antigen interactions to protect biologically active proteins and peptides
AssigneeHybrisens, Ltd.
InventorsEzekiel Y. Shami, Aser Rothstein, Mohabir Ramjeesingh
Life of this patent
Estimating the term…
Abstract
A recombinant chimeric polypeptide is produced that contains a biologically active entity and a binding entity, that displays biologically active and is inactivation resistant. The biologically active entity corresponds, for example, to an enzyme and the binding entity corresponds, for example, to an antibody. The entities interact to form a structure analagous to an antibody-antigen complex. Thus, the inactivation-resistant complex displays prolonged activity under conditions characterized by disrupting temperature, the presence of a proteolytic enzyme, disrupting pH, the presence of an oxidizing agent and/or the presence of an alcohol, among others.
Claims11
A recombinant, chimeric polypeptide chain comprising three distinct regions including a biologically active domain, a linker, and a single chain antibody wherein
- (i) the first region of said recombinant, chimeric polypeptide chain includes a biologically active domain and another domain which contains an epitope for binding to said single chain antibody;
- (ii) the second region of said recombinant, chimeric polypeptide chain includes a single chain antibody having the light and heavy chains of an antibody variable region which specifically binds to said epitope in said first region of said recombinant, chimeric polypeptide chain;
- (iii) and the third region of said recombinant, chimeric polypeptide chain includes a polypeptide linker connecting said first and second regions of said recombinant, chimeric polypeptide chain;
- and wherein said recombinant chimeric polypeptide chain assumes a conformation wherein said single chain antibody is bound to said epitope of said first region and protects the biological activity of said first region of said recombinant, chimeric polypeptide chain;
- and wherein binding to said epitope provides said biologically active domain with resistance to deactivation by a condition selected from the group consisting of denaturing temperature, denaturing pH, the presence of a proteolytic enzyme, the presence of an oxidizing agent, and the presence of alcohol;
- and wherein said biologically active domain is selected from the group consisting of an enzyme, a hormone, a growth factor, and a polypeptide drug.
Dependencies are inferred from the claim text.